|
Long-term donor support helps fund cancer breakthrough
|
Tue Jun 18 2013, 16:22 ET
|
|
New Analysis of World's Premier AIDS Conference Finds Poor Coverage of Populations Most-at-Risk for HIV
|
Tue Jun 18 2013, 13:13 ET
|
|
Currently Available Technology Can Transform Treatment and Care of Children With Chronic Diseases, New Report Says
|
Tue Jun 18 2013, 9:00 ET
|
|
RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants
|
Tue Jun 18 2013, 9:00 ET
|
|
Mei Pharma Initiates Phase II Clinical Trial Of Pracinostat And Vidaza® In Frontline Myelodysplastic Syndrome
|
Tue Jun 18 2013, 8:30 ET
|
|
Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease
|
Tue Jun 18 2013, 8:00 ET
|
|
New CISCRP study shows improvements in public perceptions of clinical research and insights into participant experiences
|
Tue Jun 18 2013, 7:00 ET
|
|
Eating Peanut Butter/Peanuts at Breakfast Helps Control Hunger and Blood Sugar All Day
|
Tue Jun 18 2013, 7:00 ET
|
|
iCo Therapeutics Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema
|
Tue Jun 18 2013, 7:00 ET
|
|
Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol"
|
Tue Jun 18 2013, 7:00 ET
|
|
Boston Scientific Vercise™ DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's Disease
|
Tue Jun 18 2013, 0:00 ET
|
|
TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
|
Mon Jun 17 2013, 22:17 ET
|
|
Purdue Pharma L.P. To Present Data Describing Changes in Oxycodone Abuse in Rural Kentucky Following the Introduction of Reformulated OxyContin® (Oxycodone HCl Controlled-Release) at the College on Problems of Drug Dependence 2013 Annual Meeting
|
Mon Jun 17 2013, 20:14 ET
|
|
Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
|
Mon Jun 17 2013, 19:00 ET
|
|
Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise™ DBS System In Treatment Of Parkinson's Disease
|
Mon Jun 17 2013, 17:03 ET
|
|
DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus
|
Mon Jun 17 2013, 16:00 ET
|
|
New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia
|
Mon Jun 17 2013, 11:30 ET
|
|
Evaluate Launches Enhanced Orphan Drug Intelligence
|
Mon Jun 17 2013, 9:51 ET
|
|
PatientsLikeMe And inVentiv Health Partner To Accelerate Clinical Trial Research
|
Mon Jun 17 2013, 9:30 ET
|
|
BioClinica Announces Completion Of The First Thorough QT Study In China And A Strategic Partnership With TEDA International Cardiovascular Hospital (TICH)
|
Mon Jun 17 2013, 9:00 ET
|
|
HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
|
Mon Jun 17 2013, 8:50 ET
|
|
AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
|
Mon Jun 17 2013, 8:15 ET
|
|
Array BioPharma Announces Positive Interim Results From Combination Trial Of ARRY-520 With Kyprolis At The 2013 European Hematology Association Congress
|
Mon Jun 17 2013, 8:00 ET
|
|
Life Technologies Expands Range of Stem Cell Reprogramming Solutions
|
Mon Jun 17 2013, 8:00 ET
|
|
A Big "LIKE" for Oral Hygiene
|
Mon Jun 17 2013, 8:00 ET
|
|
Medicago Granted Patent for Influenza Virus-Like Particles in Plants
|
Mon Jun 17 2013, 7:00 ET
|
|
CTI Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients with Myelofibrosis
|
Mon Jun 17 2013, 1:30 ET
|
|
New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
|
Mon Jun 17 2013, 1:15 ET
|
|
Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
|
Sun Jun 16 2013, 6:00 ET
|
|
Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
|
Sun Jun 16 2013, 6:00 ET
|
|
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions
|
Fri Jun 14 2013, 17:05 ET
|
|
New Long-Term Data Published in Circulation Reinforce Safety Profile of Pradaxa® (dabigatran etexilate mesylate)
|
Fri Jun 14 2013, 10:08 ET
|
|
BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013
|
Fri Jun 14 2013, 8:00 ET
|
|
Alimera Sciences Announces Issuance Of A Positive Appraisal Recommendation On ILUVIEN® For Consultation In The United Kingdom
|
Fri Jun 14 2013, 6:30 ET
|
|
Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
|
Fri Jun 14 2013, 4:00 ET
|
|
Baby Eva Named After Pioneering IVF Test
|
Fri Jun 14 2013, 1:00 ET
|
|
Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimer's Disease
|
Thu Jun 13 2013, 16:39 ET
|
|
Cempra Provides Guidance on the Clinical Program Required for Regulatory Approval for Solithromycin for Community-Acquired Bacterial Pneumonia (CABP)
|
Thu Jun 13 2013, 16:02 ET
|
|
Pharmax™ Topical Creams Use Exclusive Patented Trans-dermal Delivra™ Technology from Delivra Inc.
|
Thu Jun 13 2013, 12:33 ET
|
|
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
|
Thu Jun 13 2013, 12:14 ET
|
|
From Autism to Diabetes to Parkinson's Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
|
Thu Jun 13 2013, 10:30 ET
|
|
FDAnews Announces Clinical Trials Disclosure and Transparency Summit
|
Thu Jun 13 2013, 10:17 ET
|
|
SynteractHCR Launches Intelligent Clinical Development Platform at DIA 2013 to Support Trial Efficiencies Globally
|
Thu Jun 13 2013, 10:00 ET
|
|
Array BioPharma To Present At The Wells Fargo Securities Research And Economics 2013 Healthcare Conference
|
Thu Jun 13 2013, 9:43 ET
|
|
Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
|
Thu Jun 13 2013, 9:03 ET
|
|
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinson's Disease and Movement Disorders
|
Thu Jun 13 2013, 8:16 ET
|
|
NW Bio Has Initiated Its DCVax®-Direct Phase I/II Trial For All Solid Tumor Cancers
|
Thu Jun 13 2013, 8:15 ET
|
|
STELARA® Phase 3 Study Published In The Lancet Reports One Year Efficacy And Safety In Treatment Of Active Psoriatic Arthritis
|
Thu Jun 13 2013, 8:02 ET
|
|
New Research Demonstrates People with Narcolepsy Face Significant Health and Economic Burden and High Rates of Misdiagnosis
|
Thu Jun 13 2013, 8:00 ET
|
|
Study Shows Return of Normal Neurone Pattern Following Acoustic CR® Neuromodulation Tinnitus Treatment
|
Thu Jun 13 2013, 7:57 ET
|
